Herbalife Ltd. (NYSE:HLF) announced that the two nominees of activist investor Carl Icahn were elected to the board of directors of the nutrition and weight-loss management company during its 2013 annual general shareholders meeting today.

Herbalife

According to the company, the shareholders of Herbalife Ltd. (NYSE:HLF) voted for the election of Jonathan Christodoro and Keith Cozza to serve as Class II directors for a term of two years. The company said its shareholders also elected Leroy T. Barnes, Jr., Richard P. Bermingham, and Jeffrey T. Dunn as Class III directors for a term of three years.

In addition, the shareholders also approved the company’s executive compensation program for 2012 and the amendment of its charter for the implementation of the annual election of directors.

In a statement, Herbalife Ltd. (NYSE:HLF) wrote, “As previously announced, as part of an agreement with Carl C. Icahn, Icahn Enterprises Holdings L.P. and certain related entities (collectively the “Icahn Parties”), Herbalife agreed to nominate two individuals to the company’s board of directors, designated by the Icahn Parties and approved by the company’s Nominating and Corporate Governance Committee.”

Icahn’s company is the largest shareholder of Herbalife Ltd. (NYSE:HLF) with 15.5 percent stock holding with the right to purchase as much as 25 percent stake in the company.

Last March, Charles Garparino of Fox Business reported that the executives of the nutrition and weight-loss company expressed concerns regarding the plans of Icahn after boosting his stake. He cited statements from sources that the executives are a bit “uncomfortable” with the intentions of the activist investor. Following the report, Herbalife Ltd. (NYSE:HLF) issued a statement indicating that the company “stands by Mr. Icahn’s investment” and appreciates his shared views about the inherent value of its operations, products, and future prospects.

Meanwhile, Herbalife Ltd. (NYSE:HLF) is scheduled to report its first quarter earnings result on Monday, April 29, 2013.

The company is expected to report $1.07 earnings per share, higher than its $0.88 earnings per share in the same quarter a year earlier. The consensus estimate of analysts for its revenue for the quarter is around $1.12 billion, an increase of 16.2 percent compared with its $964.2 million revenue in the first quarter of 2012.

For fiscal 2013, analysts project that the company will deliver $4.67 earnings per share and $4.62 billion revenue. Over the previous four quarters, the company recorded double-digit revenue growth year-over-year. Its average growth rate is 18 percent. The majority of analysts recommended a buy rating for shares of Herbalife Ltd. (NYSE:HLF). The stock price of the company is trading around $37.95 per share, up by 1.82 percent on Thursday after trading hours in New York.